The Minimal Residual Disease (MRD) and diagnostic test sector moves too fast to waste months bringing a new agency up to speed. Having spent the last several years driving marketing strategy for the industry’s undisputed category leaders, HDMZ already knows the science, the stakeholders, and the market dynamics. From product naming and brand positioning to global PR and KOL engagement, we’ve built the playbooks that define this space.
The Minimal Residual Disease (MRD) and diagnostic test sector moves too fast to waste months bringing a new agency up to speed. Having spent the last several years driving marketing strategy for the industry’s undisputed category leaders, HDMZ already knows the science, the stakeholders, and the market dynamics. From product naming and brand positioning to global PR and KOL engagement, we’ve built the playbooks that define this space.













MRD-based early endpoints could reshape cancer trials. HDMZ discusses the strategic decisions MRD developers must make to align their ambitions with future clinical practice.
Moving past failed amyloid drugs, researchers are turning to CRISPR gene editing to rewrite the genetic architecture of Alzheimer’s disease. Here’s how.
Discover what makes an MRD test attractive to different oncology stakeholders—and why technical differentiation isn’t always the answer.
Explore how leading diagnostics companies like Myriad, Guardant, and Tempus are leveraging multi-modal AI and machine learning to turn raw MRD testing data into actionable oncological insights.
Done well, your brand communicates its purpose, promise, vision and personality in a manner that’s authentic, compelling and engaging. Whether you are coming out of stealth, transitioning from services to drug discovery, tackling new indications or fending off an aggressive competitor, a well-conceived corporate identity, graphic standards and brand platform can make all the difference.
At HDMZ, we understand that marketing investments only have real value when they achieve a clear business objective. It’s time to move your audience to act — build credibility, spark conversations and generate results.
All rights reserved Privacy Policy